APA (7th ed.) Citation

Sabatine, M. S., Giugliano, R. P., Keech, A., Honarpour, N., Wang, H., Liu, T., . . . Pedersen, T. R. (2016). Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial. The American heart journal, 173, 94-101. https://doi.org/10.1016/j.ahj.2015.11.015

Chicago Style (17th ed.) Citation

Sabatine, Marc S., et al. "Rationale and Design of the Further Cardiovascular OUtcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk Trial." The American Heart Journal 173 (2016): 94-101. https://doi.org/10.1016/j.ahj.2015.11.015.

MLA (9th ed.) Citation

Sabatine, Marc S., et al. "Rationale and Design of the Further Cardiovascular OUtcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk Trial." The American Heart Journal, vol. 173, 2016, pp. 94-101, https://doi.org/10.1016/j.ahj.2015.11.015.